| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |